The estimated Net Worth of Keith R Dunleavy is at least $19.4 Milion dollars as of 30 October 2020. Keith Dunleavy owns over 60,000 units of Innovator ETFs Trust stock worth over $19,212,600 and over the last 9 years he sold INOV stock worth over $0. In addition, he makes $210,551 as Chairman of the Board a Chief Executive Officer at Innovator ETFs Trust.
Sign up
Keith Dunleavy INOV stock SEC Form 4 insiders trading
Keith has made over 9 trades of the Innovator ETFs Trust stock since 2015, according to the Form 4 filled with the SEC. Most recently he bought 60,000 units of INOV stock worth $1,177,200 on 30 October 2020.
The largest trade he's ever made was buying 136,995 units of Innovator ETFs Trust stock on 10 May 2019 worth over $1,837,103. On average, Keith trades about 66,000 units every 189 days since 2015. As of 30 October 2020 he still owns at least 660,000 units of Innovator ETFs Trust stock.
You can see the complete history of Keith Dunleavy stock trades at the bottom of the page.
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Keith Dunleavy biography
Dr. Keith R. Dunleavy, M.D., is Chairman of the Board, Chief Executive Officer of the INOVALON HOLDINGS, INC. Dr. Dunleavy has served as our Chief Executive Officer since his organization of our predecessor companies in 1998, as Chairman of the Board since the creation of the Board in 2006, and as President from our foundation until May of 2014. Dr. Dunleavy is responsible for the overall execution of our business plan, strategic relationships, and the identification and realization of our product strategy and vision. During his tenure building Inovalon, Dr. Dunleavy has worked extensively with a wide array and number of healthcare organizations, regulatory and oversight bodies, and technology companies examining the growing role of data within healthcare, and its ability to drive meaningful insight and improvement for its constituents. Dr. Dunleavy received a Bachelor’s degree in Biology modified with Engineering with High Honors from Dartmouth College, where his studies and work focused upon the neurosciences, computer sciences and engineering, and his honors thesis focused on the computer simulation of artificial human cerebellar functional units. He earned his doctorate in medicine from Harvard Medical School, completed his medical residency at The Johns Hopkins Hospital in Baltimore, Maryland, and practiced and was Board Certified in Internal Medicine. Dr. Dunleavy serves as a Director on the Dartmouth Medical School Board of Advisors.
What is the salary of Keith Dunleavy?
As the Chairman of the Board a Chief Executive Officer of Innovator ETFs Trust, the total compensation of Keith Dunleavy at Innovator ETFs Trust is $210,551. There are 10 executives at Innovator ETFs Trust getting paid more, with Peter De Bock having the highest compensation of $2,866,730.
How old is Keith Dunleavy?
Keith Dunleavy is 50, he's been the Chairman of the Board a Chief Executive Officer of Innovator ETFs Trust since 2006. There are 10 older and 2 younger executives at Innovator ETFs Trust. The oldest executive at Innovator ETFs Trust is Denise Fletcher, 71, who is the Independent Director.
What's Keith Dunleavy's mailing address?
Keith's mailing address filed with the SEC is 4321, Collington Road, Essington, Bowie, Prince George's County, Maryland, 20716, United States.
Insiders trading at Innovator ETFs Trust
Over the last 10 years, insiders at Innovator ETFs Trust have traded over $17,222,256 worth of Innovator ETFs Trust stock and bought 1,096,675 units worth $14,934,745 . The most active insiders traders include Keith R Dunleavy, Christopher E Greiner a William D Green. On average, Innovator ETFs Trust executives and independent directors trade stock every 36 days with the average trade being worth of $987,207. The most recent stock trade was executed by William J Jr Teuber on 18 June 2021, trading 9,165 units of INOV stock currently worth $266,793.
What does Innovator ETFs Trust's logo look like?
Complete history of Keith Dunleavy stock trades at Innovator ETFs Trust
Innovator ETFs Trust executives and stock owners
Innovator ETFs Trust executives and other stock owners filed with the SEC include:
-
Peter De Bock,
Chief Administrative Officer -
Jonathan Boldt,
Chief Financial Officer -
Jason Capitel,
Chief Operating Officer -
Robert Wychulis,
President -
Isaac Kohane,
Independent Director -
William Teuber,
Independent Director -
Lee Roberts,
Independent Director -
William Green,
Independent Director -
Denise Fletcher,
Independent Director -
Mark Pulido,
Non-Independent Director -
Dr. Keith R. Dunleavy,
Founder, Chairman & CEO -
Keith Dunleavy,
Chairman of the Board, Chief Executive Officer -
Andre Hoffmann,
Independent Director -
Dr. Paige C. Kilian M.D.,
Chief Medical Officer -
Ingrid E. Olsen,
Chief People Officer -
Kim E. Collins,
Sr. VP of Corp. Marketing & Communications -
Beverly Allen,
Gen. Counsel, Chief Compliance & Privacy Officer -
Hulus Alpay,
VP of Investor Relations -
Geoff Charron,
Chief Technology Officer -
June Duchesne,
Chief Legal Officer -
Shauna L Vernal,
Chief Legal Officer -
Joseph R Rostock,
Chief Technology Officer -
Daniel L Rizzo,
Chief Innovation Officer -
Thomas R Kloster,
Chief Financial Officer -
Christopher E Greiner,
Chief Product Officer & COO -
John Michael Burgin,
Chief Product Officer -
Eron Kelly,
President